Clinically-enhanced digital health program for respiratory care associated with better medication use and retention Leanne Kaye Vy Vuong Meredith A. Barrett ResearchOpen Access28 Dec 2024npj Primary Care Respiratory Medicine Volume: 34, P: 46
AstraZeneca, said: “Our broad pipeline and portfolio of inhaled and biologic medicines are the cornerstone of our bold ambition to transform respiratory care. COPD remains one of the leading causes of death globally, and at ATS we will present important real-world evidence reinforcing the ...
December 9, 2024 · 2 min read · Tristan Manalac Bladder cancer Protara, CG Oncology Tout Promising Bladder Cancer Outcomes December 6, 2024 · 2 min read · Tristan Manalac Cancer AstraZeneca/Daiichi Sankyo, BioNTech, M...
Poster 484: How Much Improvement In Subject-Reported Sleep Onset Latency Is Needed for Patients to Report a Positive Impact of Their Insomnia Medication? Poster 486: Impact of Intrinsic Factors on Efficacy of Lemborexant: Subgroup Analyses o...
Organ transplantation is an expensive therapy; apart from the charges associated with organ procurement and transplantation, there are significant costs associated with the recipient’s aftercare and anti-rejection medication. In addition, costs may include travel, lodging, and meals, whenever the patien...
aCOPD patients were significantly more confident that they had taken the medication successfully with Breezhaler vs Handihaler COPD患者是更他们成功地采取了疗程与Breezhaler对Handihaler的确信[translate] aAnti- Dumping duties 反倾销税[translate] aAdd a Payment Method 增加付款方法[translate] ...
aSome inhaler devices lack feedback mechanisms, and COPD patients want assurance that they have taken their medication correctly 一些吸入器设备缺乏反馈机制和COPD患者想要保证他们正确地采取了他们的疗程[translate] ahaphazard 随便[translate] aReorganizes the mood 整顿心情[translate] ...
After adjusting for potential confounders, they found that antihypertensive medications were added or the dose of medication increased in about one-third of patients regardless of the degree of nonadherence in the previous year. LABAs improve COPD Inhaled long-acting beta2-agonists (LABAs) improve ...
Inhaler misuse leads to mismanagement of COPD symptoms and increased exacerbations, research finds Inhaler misuse leading to inadequate medication delivery impacts a person's ability to manage symptoms of chronic obstructive pulmonary disease (COPD), and additional education about proper inhaler use is nee...
Patients with pulmonary arterial hypertension (PAH), a severe, progressive condition that affects the heart and lungs, who were treated with the novel first-in-class medication sotatercept on top of existing therapy experienced ... Mar 7, 2023 ...